- | Academic & Student Programs Academic & Student Programs
- | Essays Essays
- |
Free to choose medicine: Better drugs sooner at lower cost (2nd edition)
Bartley J. Madden
Originally published in The Review of Austrian Economics
Despite this role, Bartley J. Madden argues in his book Free to Choose Medicine: Better Drugs, Sooner, at Lower Cost, that rather than serving the interests of patients, the FDA actually hurts Americans due to its long and demanding drug-approval process. He contends that the agency’s primary motivation has become to preserve its own reputation and to minimize its liabilities. And he makes the case for restructuring the FDA to better protect the health and medical safety of Americans.
Despite this role, Bartley J. Madden argues in his book Free to Choose Medicine: Better Drugs, Sooner, at Lower Cost, that rather than serving the interests of patients, the FDA actually hurts Americans due to its long and demanding drug-approval process. He contends that the agency’s primary motivation has become to preserve its own reputation and to minimize its liabilities. And he makes the case for restructuring the FDA to better protect the health and medical safety of Americans.
Read the full article at SpringerLink.
To speak with a scholar or learn more on this topic, visit our contact page.